Shirakawa, Tsuyoshi
Makiyama, Akitaka
Shimokawa, Mototsugu
Otsuka, Taiga
Shinohara, Yudai
Koga, Futa
Ueda, Yujiro
Nakazawa, Junichi
Otsu, Satoshi
Komori, Azusa
Arima, Shiho
Fukahori, Masaru
Taguchi, Hiroki
Honda, Takuya
Shibuki, Taro
Nio, Kenta
Ide, Yasushi
Ureshino, Norio
Mizuta, Toshihiko
Mitsugi, Kenji
Akashi, Koichi
Baba, Eishi
Article History
Received: 19 February 2023
Accepted: 10 May 2023
First Online: 31 May 2023
Change Date: 4 March 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41598-024-55673-7
Competing interests
: M.S. received a personal fee from Sysmex Corporation; S.A. received personal fees from Taiho Pharmaceutical, Novartis Pharma, Chugai, Bristol-Myers Squibb, Daiichi-Sankyo, and AstraZeneca; A.M. received personal fees from Eli Lilly, Taiho Pharmaceutical, Ono Pharmaceutical, Bristol-Myers Squibb and Daiichi-Sankyo. The remaining authors have no competing interests or financial disclosures to declare.